PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.270
-0.020 (-1.55%)
Jul 10, 2025, 4:00 PM - Market closed
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $65.98 million as of July 11, 2025. Its market cap has decreased by -20.58% in one year.
Market Cap
65.98M
Enterprise Value
-98.74M
1-Year Change
-20.58%
Ranking
Category
Stock Price
$1.27
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $65.98M, a decrease of -95.91%. That is a compound annual growth rate of -48.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2025 | 67.02M | -14.23% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | 2.75B | 70.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.13B |
| Johnson & Johnson | 374.84B |
| AbbVie | 335.21B |
| Novo Nordisk | 313.36B |
| UnitedHealth Group | 279.13B |
| Novartis AG | 240.15B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 217.48B |